Testing effectiveness (Phase 2)Not Yet RecruitingNCT07451236
What this trial is testing
CD19-BCMA Dual Nanobody Based CAR-T Cells for Patients With DSA
Who this might be right for
Transplantation Candidates With Hematological Diseases
Chang Yingjun 18